REG - Informa PLC - Transaction in Own Shares

InformaAnnouncement

11/07/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220711:nRSK9169Ra&default-theme=true

RNS Number : 9169R  Informa PLC  11 July 2022

Informa PLC Press Release

11 July 2022

Informa Share Buyback Programme

Update on GAP II shareholder returns

Informa (LSE: INF.L), the international B2B Markets, Knowledge Services and
Business Intelligence Group today provided an update on its Share Buyback
Programme that forms part of the 2021-2024 Growth Acceleration Plan II ('GAP
II').

Share Buyback Programme

GAP II is Informa's four-year programme to create a more focused, higher
growth business. This will see the Group accelerate investment in its two
businesses with scale leadership positions, B2B Markets and Academic Markets,
and divest of its Informa Intelligence portfolio of businesses.

As announced on 16 June 2022, following completion of the Pharma Intelligence
divestment, the Company further expanded its Share Buyback Programme to
£725m, an increase from the £300m announced within the Company's 2021 Full
Year Results Statement on 15 March. This represents c.50% of the post-tax cash
proceeds received to date from the delivery of GAP II Portfolio Focus.

As part of this extension, on 08 July 2022, the Company purchased 502,316
ordinary shares for cancellation through Merrill Lynch International at an
average price of 538.6420 pence per share.

The highest and lowest purchase price paid per share were 543.4p and 532.8p
respectively, with the aggregate details of shares purchased by trading venue
as outlined in the table below:

 Trading venue          Weighted average price paid per share (GBp)  Aggregate number of shares purchased  Lowest price paid per share  Highest price paid per share

(GBp)
(GBp)
 London Stock Exchange  538.7062                                     337,000                               532.8000                     543.4000
 Chi-X (CXE)            538.7190                                     103,985                               533.0000                     543.0000
 BATS (BXE)             538.1582                                     61,331                                532.8000                     543.4000

Following settlement of the above purchases and cancellation of the purchased
ordinary shares, the Company's total number of ordinary shares in issue, and
its total voting rights, will be 1,454,658,748 ordinary shares.  The Company
does not hold any shares in Treasury.

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full
breakdown of the individual trades made as part of the buyback programme is
detailed in the attachment.

http://www.rns-pdf.londonstockexchange.com/rns/9169R_1-2022-7-8.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/9169R_1-2022-7-8.pdf)

 Enquiries
 Richard Menzies-Gow, Director of IR & Communications      +44 (0) 20 8052 2787
 Heledd Hanscomb, Deputy Company Secretary                 +44 (0) 20 8052 0661

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSBLGDRUXGDGDI